Glenmark gets ANDA nod for Deferasirox tablets for oral suspension

According to IQVIA sales data for the 12month period ending November 2019, the Exjade Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg market achieved annual sales of ~$106.4 mn.

from India Infoline News Service https://ift.tt/2N2Oe7h